Type 2 Diabetes

A cholesterol-lowering drug cuts cardiovascular disease risks by 30-percent in women with type-2 diabetes.

Jardiance (empagliflozin) tablets have been approved by the FDA as an addition to diet and exercise to improve glycemic control in type 2 diabetic adults.

For type 2 diabetics - especially those over age 50 - the negative impact of side effects like weight gain and burdens like frequent insulin shots trumps the benefits of drugs.

Among diabetics who were receiving metformin, the addition of insulin compared with a certain class of antidiabetic drugs was associated with an increased risk of nonfatal cardiovascular outcomes and all-cause death.

In a study that included long-term follow-up of obese patients with type 2 diabetes, bariatric surgery was associated with more frequent diabetes remission and fewer complications than patients who received usual care.

A new study has demonstrated a link between obstructive sleep apnea (OSA) and the development of diabetes.

Find out how much the use of insulin among patients with type 2 diabetes and out-of-pocket expenditures per prescription have increased.

Studies have shown that diabetics have about twice the odds of suffering from depression, which further increases the risk of premature death and mortality risk.

Researchers may have found a novel way to suppress the devastating side effect of one of the worlds' most widely used drugs to lower cholesterol and prevent heart disease.

Researchers have identified a variant in the Latino population that was associated with a 5-fold increase in the prevalence of type 2 diabetes.

Newly discovered compound slows the natural degradation of insulin in the body, opening the door to a potential new treatment for diabetes.

Although obesity is a risk factor for diabetes and heart disease, some people who are overweight or obese are able to delay or avoid developing related key risk factors.

A signal that promotes insulin secretion and reduces hyperglycemia in a type 2 diabetes animal model is enhanced by the inhibition of a novel enzyme discovered by researchers.

GenStrips are advertised for use with the LifeScan OneTouch family of glucose meters. The affected test strips have been manufactured and distributed since March 2013 and are available through online retailers and retail pharmacies.

Dangerous overnight blood sugar levels often go undetected and cause prolonged periods of heart rhythm disturbances in older patients with Type 2 diabetes.

People who increased the amount of coffee they drank each day by more than one cup over a four-year period had a 11% lower risk for type 2 diabetes